DK1799707T3 - Rekombineret Kunitztypeinhibitor - Google Patents

Rekombineret Kunitztypeinhibitor

Info

Publication number
DK1799707T3
DK1799707T3 DK05782904.6T DK05782904T DK1799707T3 DK 1799707 T3 DK1799707 T3 DK 1799707T3 DK 05782904 T DK05782904 T DK 05782904T DK 1799707 T3 DK1799707 T3 DK 1799707T3
Authority
DK
Denmark
Prior art keywords
kunitztype
recombined
inhibitor
recombined kunitztype
kunitztype inhibitor
Prior art date
Application number
DK05782904.6T
Other languages
English (en)
Inventor
Ana Marisa Chudzinski-Tavassi
Durvanel Augusto Maria
Isabel De Fatima Correia Batista
Paulo Lee Ho
Original Assignee
Uniao Quimica Farmaceutica Nac S A
Fundacao De Amparo A Pesquisa Do Estado De Sao Paulo
Chudzinski Tavassi Ana Marisa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniao Quimica Farmaceutica Nac S A, Fundacao De Amparo A Pesquisa Do Estado De Sao Paulo, Chudzinski Tavassi Ana Marisa filed Critical Uniao Quimica Farmaceutica Nac S A
Application granted granted Critical
Publication of DK1799707T3 publication Critical patent/DK1799707T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
DK05782904.6T 2004-09-15 2005-09-15 Rekombineret Kunitztypeinhibitor DK1799707T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0406057-1A BRPI0406057B1 (pt) 2004-09-15 2004-09-15 Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
PCT/BR2005/000185 WO2006029492A1 (en) 2004-09-15 2005-09-15 Kunitz-type recombinant inhibitor.

Publications (1)

Publication Number Publication Date
DK1799707T3 true DK1799707T3 (da) 2013-05-21

Family

ID=36273230

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05782904.6T DK1799707T3 (da) 2004-09-15 2005-09-15 Rekombineret Kunitztypeinhibitor

Country Status (10)

Country Link
US (1) US8440795B2 (da)
EP (1) EP1799707B1 (da)
JP (1) JP4980220B2 (da)
CN (1) CN101142232B (da)
AU (1) AU2005284615B2 (da)
BR (1) BRPI0406057B1 (da)
CA (2) CA2581001C (da)
DK (1) DK1799707T3 (da)
ES (1) ES2410160T3 (da)
WO (1) WO2006029492A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0406057B1 (pt) 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
AU2008226358A1 (en) * 2007-03-14 2008-09-18 Ana Marisa Chudzinski-Tavassi Kunitz-type recombinant inhibitor
KR102165021B1 (ko) * 2008-12-19 2020-10-14 박스알타 인코퍼레이티드 Tfpi 억제제 및 사용 방법
US8772238B2 (en) 2009-03-18 2014-07-08 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
BR102018074037A2 (pt) * 2018-11-22 2021-05-11 Inst Butantan composto para direcionar entidades moleculares para o domínio intracelular de células neoplásicas, ingrediente farmacêutico ativo compreendendo o referido composto, composição farmacêutica, método para o diagnóstico, prognóstico e/ou tratamento de câncer
BR102018074043A2 (pt) * 2018-11-22 2020-06-02 Inst Butantan composto para a modulação de vias de rlr, tlr, oas e/ou oncostatina m, uso do mesmo para a preparação de um medicamento, composição e método para modulação das ditas vias

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006207C2 (de) * 1980-02-15 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Elektrische Maschine mit einem Ständerblechpaket aus kornorientierten Blechen
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
BRPI0406057B1 (pt) 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante

Also Published As

Publication number Publication date
EP1799707B1 (en) 2013-03-27
BRPI0406057B1 (pt) 2021-10-26
EP1799707A1 (en) 2007-06-27
CA2680759A1 (en) 2008-09-18
JP4980220B2 (ja) 2012-07-18
BRPI0406057A (pt) 2006-05-02
WO2006029492A1 (en) 2006-03-23
US20090042786A1 (en) 2009-02-12
ES2410160T3 (es) 2013-07-01
CA2581001A1 (en) 2006-03-23
CN101142232B (zh) 2013-03-13
US8440795B2 (en) 2013-05-14
AU2005284615B2 (en) 2011-03-31
JP2008512992A (ja) 2008-05-01
AU2005284615A1 (en) 2006-03-23
CN101142232A (zh) 2008-03-12
CA2581001C (en) 2011-05-03

Similar Documents

Publication Publication Date Title
CY2019034I1 (el) 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια
DK1586319T3 (da) Thiadiazolidinoner som GSK-3-inhibitorer
DE502005005116D1 (de) Wischblatt
DE502005005035D1 (de) Wischblatt
DE112005001624A5 (de) Brillengestell
ATE392425T1 (de) Thiazolyl-dihydro-indazole
ATE520680T1 (de) Hiv-hemmende 5-heterocyclylpyrimidine
ATE459633T1 (de) Makrolide
DE502005004843D1 (de) Einspritzventil
DE602004018837D1 (de) Ptidase-iv-inhibitoren
DE502005004842D1 (de) Wischblatt
DE112005000809A5 (de) Wankstabilisierungseinrichtung
DE602005004840D1 (de) Erntegutabstreifer
DE502005002602D1 (de) Fahrzeugtemperiersystem
DE502004006772D1 (de) Wirkwerkzeug-Barre
DK1799707T3 (da) Rekombineret Kunitztypeinhibitor
DE502005004695D1 (de) Sicherheitsfangseil
DE502004012213D1 (de) Flachdichtung
DE602005009376D1 (de) Tankbioauslaugungsverfahren
AT500198B8 (de) Ladewagen
DE202004017327U1 (de) Fitnessrad
ATE389633T1 (de) Omega-phenyloctanamide
DE112005000794T5 (de) Urethanspritzpistolenanordnung
SE0400476L (sv) Komponent
DE502005004160D1 (de) Seitenblinkleuchte